ArticleAnnals of pediatric cardiology
Impact on post-transplantation outcomes in pediatric patients undergoing heart-lung transplantation by recipient age at the time of transplantation.
Article in Annals of pediatric cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The impact of age at transplantation on the outcomes of pediatric heart-lung transplantation (HLTX) recipients is not well described. Methods: The UNOS database (1987-2023) was retrospectively queried for primary pediatric HLTX in patients ≤18 year of age. The cohort was dichotomized into ages <12 years (Young group [YG]) and ≥12 years (Old group [OG]) due to its impact on the previously used lung allocation score (LAS). The data were extracted for clinic characteristics and outcomes. Standard statistical tests were used. Results: 217 (113 YG, 104 OG) patients underwent HTLX. The median age of YG was 4 years, compared to 15 years in OG ( Conclusion: There is a declining trend in HLTX in pediatric patients, with fewer YG patients. The long-term survival of YG was inferior. Recipient age and ECMO bridge were the only independent predictors of mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.